ES2151118T3 - Evaluacion de substancias para aumentar y para modificar la actividad para la apc. - Google Patents

Evaluacion de substancias para aumentar y para modificar la actividad para la apc.

Info

Publication number
ES2151118T3
ES2151118T3 ES96117704T ES96117704T ES2151118T3 ES 2151118 T3 ES2151118 T3 ES 2151118T3 ES 96117704 T ES96117704 T ES 96117704T ES 96117704 T ES96117704 T ES 96117704T ES 2151118 T3 ES2151118 T3 ES 2151118T3
Authority
ES
Spain
Prior art keywords
apc
modify
evaluation
substances
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96117704T
Other languages
English (en)
Inventor
Jan Dr Rosing
Guido Dr Tans
Katalin Dr Varadi
Hans-Peter Doz Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2151118T3 publication Critical patent/ES2151118T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96463—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G01N2405/04—Phospholipids, i.e. phosphoglycerides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA METODOS, REACTIVOS Y EQUIPAMIENTO PARA ENSAYOS, PARA EVALUAR EL EFECTO DE UNA COMPOSICION DE ENSAYO RESPECTO A LA RESPUESTA FRENTE A APC, MEDIANTE EL EMPLEO DEL FACTOR VA{SUP,R506Q}. SE PROPORCIONAN ASIMISMO, METODOS Y COMPOSICIONES PARA TRATAR A PACIENTES QUE PRESENTAN UNA RESPUESTA REDUCIDA FRENTE A APC.
ES96117704T 1995-11-09 1996-11-05 Evaluacion de substancias para aumentar y para modificar la actividad para la apc. Expired - Lifetime ES2151118T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/555,423 US5863896A (en) 1995-11-09 1995-11-09 Evaluation of substances for altering and for increasing APC response

Publications (1)

Publication Number Publication Date
ES2151118T3 true ES2151118T3 (es) 2000-12-16

Family

ID=24217207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96117704T Expired - Lifetime ES2151118T3 (es) 1995-11-09 1996-11-05 Evaluacion de substancias para aumentar y para modificar la actividad para la apc.

Country Status (5)

Country Link
US (1) US5863896A (es)
EP (1) EP0776980B1 (es)
AT (1) ATE195151T1 (es)
DE (1) DE69609586T2 (es)
ES (1) ES2151118T3 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690644B2 (en) * 1994-02-14 1998-04-30 Rijksuniversiteit Leiden A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein C
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
JP2008507561A (ja) * 2004-07-23 2008-03-13 ザ ユニバーシティ オブ ロチェスター 活性化プロテインｃによる、脳内のプラスミノゲン活性化因子の不都合な作用の阻害

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389815B (de) * 1984-03-09 1990-02-12 Immuno Ag Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
US5254532A (en) * 1989-06-26 1993-10-19 Immuno Aktiengesellschaft Fur Chemisch-Medizinische Produkte Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same
AT402262B (de) * 1991-06-20 1997-03-25 Immuno Ag Arzneimittel enthaltend aktiviertes protein c
ES2142317T3 (es) * 1991-07-02 2000-04-16 Scripps Research Inst Polipeptidos de proteinas s y uso de los mismos.
WO1994017415A1 (en) * 1993-01-29 1994-08-04 Dahlbaeck Bjoern Novel anticoagulant cofactor activity
AU6985594A (en) * 1993-06-30 1995-01-24 Bonno Nammen Bouma Protein s deletion variants deficient in c4bp binding activity, but having apc cofactor activity, compositions and therapeutic methods
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen

Also Published As

Publication number Publication date
DE69609586D1 (de) 2000-09-07
ATE195151T1 (de) 2000-08-15
DE69609586T2 (de) 2001-04-05
EP0776980B1 (en) 2000-08-02
EP0776980A1 (en) 1997-06-04
US5863896A (en) 1999-01-26

Similar Documents

Publication Publication Date Title
DE69632447D1 (de) Analysator zur Analyse von Urinbestandteilen
NO975598D0 (no) Monoklonale ape-antistoffer som er spesifikke for primatiserte humane B7.1- og/eller B7.2-former, samt farmasöytiske sammensetninger
DE69321218D1 (de) Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
DK1489082T3 (da) Mellemprodukter
EP0844882A4 (en) REGULATORY COMPOSITIONS OF APPETITE
ATE407221T1 (de) Diagnostika für fragile plaque störung
FI973122L (fi) Menetelmä ja yhdisteitä analysoitavien aineiden detektoimiseksi magnetorelaksometrisesti ja niiden käyttö
EP1461061A4 (en) COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF DISEASES AND CONDITIONS RELATED TO CHEMOKINE RECEPTORS
DE69520605D1 (de) Verbesserte prallplatte für hufeisen
DE69617148D1 (de) Fühlerprobe
NO974322L (no) DNA som koder for human papillomvirus type 18
DE69622978D1 (de) Analysator zur Analyse von Urinbestandteilen
DE59010919D1 (de) N- und O-substituierte Aminophenolderivate, Zwischenprodukte zu deren Herstellung, deren Verwendung als Hydrolasesubstrate, ein entsprechendes Bestimmungsverfahren und hierfür geeignetes diagnostisches Mittel
DE69415318D1 (de) Biologischer Sterilisationsindikator, Testvorrichtung, die den gleichen enthält, und deren Verwendung
CA2212043A1 (en) Method for assay of analyte by adjustment of chemiluminescence
EP0836652A4 (en) METHODS, KITS AND COMPOSITIONS FOR DIAGNOSING PAPILLOMA VIRUS INFECTION
ATE195151T1 (de) Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität
FI974424A0 (fi) Varhainen diagnostinen testi
ATE253223T1 (de) Verfahren und materialien zur diagnose instabiler angina
DE69623648D1 (de) Ablenkungsmechanismus fur schiffskörper
AU6621396A (en) Diagnostic test for schizophrenia by analysing allelic variations in the cytosolic phospholipase a2 gene
DE60117743D1 (de) Screeningverfahren für Modulatoren von Integrinen
ES2116241B1 (es) Composicion para la obtencion de un aguardiente.
ES1037980Y (es) "dispositivo alveolar para muestras de analisis".

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 776980

Country of ref document: ES